Physician
Mawan Shuayto MD PC
Mawan Shuayto MD PC was paid $7.78M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 13% of everything it billed.
33Billing provider infoMAWAN SHUAYTO MD PC
PORT HURON, MI 48060
PORT HURON, MI 48060
33aNPI1578819850assigned 07/24/2012
33bProvider typeDiagnostic Radiology Physician
28Total paid$7.78M
24GClaims230,421
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Diagnostic Radiology Physician providers in Michigan
Rank by total paid#10 of 139
Median peer was paid$28K
This provider vs. median277×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,609 | $1.05M | |
| 2019 | 38,618 | $1.15M | |
| 2020 | 28,117 | $927K | |
| 2021 | 30,860 | $1.11M | |
| 2022 | 34,118 | $1.30M | |
| 2023 | 32,849 | $1.25M | |
| 2024incomplete | 25,250 | $1.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13% | 24,074 | 22,434 | $983K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.9% | 11,900 | 11,515 | $694K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 8.6% | 8,945 | 8,711 | $667K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 6.9% | 1,171 | 623 | $538K |
| 95886 | 6.0% | 4,621 | 3,740 | $466K | |
| 62323 | 3.7% | 2,570 | 2,497 | $287K | |
| 95911 | 3.6% | 2,435 | 2,333 | $282K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.3% | 22,287 | 20,883 | $260K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 3.1% | 2,579 | 2,324 | $239K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.0% | 11,990 | 3,161 | $234K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.9% | 12,182 | 3,161 | $224K |
| 95910 | 2.7% | 2,151 | 2,120 | $209K |
96 more codes
| 62321 | 2.3% | 1,752 | $180K | |
| 76942 | 2.3% | 7,310 | $177K | |
| 95812 | 2.2% | 952 | $175K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2.0% | 1,612 | $159K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.8% | 1,635 | $142K |
| 72141 | 1.8% | 1,571 | $141K | |
| 99213 | Doctor's office visit, returning patient (routine) | 1.8% | 3,474 | $137K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 1.7% | 6,671 | $132K |
| 99205 | Prolong outpt/office vis | 1.6% | 1,197 | $126K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1.4% | 714 | $112K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 15,638 | $97K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1.2% | 5,259 | $96K |
| 20611 | 1.1% | 2,198 | $84K | |
| 64505 | <1% | 604 | $53K | |
| 70544 | <1% | 490 | $50K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,593 | $47K |
| 20553 | <1% | 1,622 | $47K | |
| 64635 | <1% | 304 | $44K | |
| 72110 | <1% | 1,670 | $43K | |
| 64483 | <1% | 455 | $40K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 814 | $40K |
| 97162 | <1% | 688 | $37K | |
| 72050 | <1% | 1,189 | $32K | |
| 64400 | <1% | 621 | $30K | |
| 77002 | <1% | 531 | $30K | |
| 92546 | <1% | 478 | $30K | |
| 64405 | <1% | 768 | $28K | |
| 62370 | <1% | 576 | $25K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14,495 | $24K |
| 64636 | <1% | 359 | $22K | |
| 64615 | <1% | 345 | $19K | |
| 64484 | <1% | 450 | $17K | |
| 64451 | <1% | 173 | $16K | |
| 27096 | <1% | 241 | $15K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,590 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 890 | $14K |
| 64493 | <1% | 166 | $14K | |
| 99490 | Ccm add 20min | <1% | 1,442 | $13K |
| 20610 | <1% | 524 | $12K | |
| 95930 | <1% | 288 | $10K | |
| 72114 | <1% | 308 | $10K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 354 | $10K |
| 20526 | <1% | 266 | $9K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 84 | $8K |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 13 | $8K |
| 76080 | <1% | 272 | $8K | |
| 64490 | <1% | 78 | $8K | |
| 72156 | <1% | 53 | $8K | |
| 64494 | <1% | 168 | $7K | |
| 92653 | <1% | 139 | $7K | |
| 82962 | <1% | 3,579 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,659 | $7K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 87 | $6K |
| 72052 | <1% | 216 | $6K | |
| 72070 | <1% | 322 | $5K | |
| 70549 | <1% | 25 | $5K | |
| 97164 | <1% | 136 | $5K | |
| 92585 | <1% | 74 | $5K | |
| 99223 | Prolong inpt eval add15 m | <1% | 54 | $5K |
| 97035 | <1% | 666 | $4K | |
| 72146 | <1% | 42 | $4K | |
| 92542 | <1% | 192 | $3K | |
| 73221 | <1% | 26 | $3K | |
| 73564 | <1% | 100 | $3K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 535 | $3K |
| 92540 | <1% | 38 | $2K | |
| 64495 | <1% | 63 | $2K | |
| 92547 | <1% | 479 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 102 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,462 | $1K |
| 96130 | <1% | 16 | $978.53 | |
| 99408 | <1% | 78 | $970.69 | |
| 64633 | <1% | 18 | $932.27 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,460 | $908.97 |
| 20551 | <1% | 39 | $851.66 | |
| 72074 | <1% | 40 | $815.03 | |
| 73030 | <1% | 77 | $679.84 | |
| 73502 | <1% | 27 | $670.28 | |
| 72157 | <1% | 12 | $627.00 | |
| 97014 | <1% | 75 | $499.72 | |
| 96136 | <1% | 15 | $368.89 | |
| 94760 | <1% | 12,269 | $329.57 | |
| 73503 | <1% | 12 | $289.20 | |
| 96138 | <1% | 13 | $197.46 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 1,204 | $93.34 |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 13 | $83.86 |
| J1815 | Injection, insulin, per 5 units | <1% | 14 | $75.62 |
| 99358 | Prolong nursin fac eval 15m | <1% | 60 | $66.39 |
| 99406 | <1% | 12 | $48.72 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 46 | $40.16 |
| A4615 | Cannula, nasal | <1% | 224 | $10.87 |
| H0049 | Alcohol and/or drug screening | 0% | 324 | $0.00 |
| G9854 | Patient was not admitted to the icu in the last 30 days of life | 0% | 60 | $0.00 |
| 97010 | 0% | 142 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 289 | $0.00 |
| G9584 | Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHUAYTO, MARWAN (PHYSICIAN)
Parent organizationMAWAN SHUAYTO MD PC